Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

被引：1134

作者：

Dai, Wenhao ^{[1
,2
]}

Zhang, Bing ^{[3
,4
]}

Jiang, Xia-Ming ^{[5
]}

Su, Haixia ^{[1
,6
]}

Li, Jian ^{[1
,6
]}

Zhao, Yao ^{[3
,4
]}

Xie, Xiong ^{[1
,6
]}

Jin, Zhenming ^{[3
,4
]}

Peng, Jingjing ^{[1
,6
]}

Liu, Fengjiang ^{[3
,4
]}

Li, Chunpu ^{[1
,6
]}

Li, You ^{[8
]}

Bai, Fang ^{[3
,4
]}

Wang, Haofeng ^{[3
,4
]}

Cheng, Xi ^{[1
]}

Cen, Xiaobo ^{[8
]}

Hu, Shulei ^{[1
]}

Yang, Xiuna ^{[3
,4
]}

Wang, Jiang ^{[1
,6
]}

Liu, Xiang ^{[9
]}

Xiao, Gengfu ^{[5
]}

Jiang, Hualiang ^{[1
,3
,4
,6
]}

Rao, Zihe ^{[3
,4
]}

Zhang, Lei-Ke ^{[5
]}

Xu, Yechun ^{[1
,6
]}

Yang, Haitao ^{[3
,4
]}

Liu, Hong ^{[1
,2
,6
,7
]}

机构：

[1] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, State Key Lab Drug Res, Shanghai 201203, Peoples R China

[2] China Pharmaceut Univ, Sch Pharm, Nanjing 210009, Jiangsu, Peoples R China

[3] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China

[4] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China

[5] Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China

[6] Univ Chinese Acad Sci, Beijing 100049, Peoples R China

[7] Nanjing Univ Chinese Med, Coll Pharm, Nanjing 210023, Peoples R China

[8] Sichuan Univ, Westchina Hosp, Natl Chengdu Ctr Safety Evaluat Drugs, Chengdu 610041, Sichuan, Peoples R China

[9] Nankai Univ, State Key Lab Med Chem Biol, Frontiers Sci Ctr Cell Response, Coll Pharm,Coll Life Sci, Tianjin 300353, Peoples R China

来源：

SCIENCE | 2020年 / 368卷 / 6497期

基金：

中国国家自然科学基金;

关键词：

CORONAVIRUS; INHIBITORS; 3C;

D O I：

10.1126/science.abb4489

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the etiological agent responsible for the global COVID-19 (coronavirus disease 2019) outbreak. The main protease of SARS-CoV-2, M-pro, is a key enzyme that plays a pivotal role in mediating viral replication and transcription. We designed and synthesized two lead compounds (11a and 11b) targeting M-pro. Both exhibited excellent inhibitory activity and potent anti-SARS-CoV-2 infection activity. The x-ray crystal structures of SARS-CoV-2 M-pro in complex with 11a or 11b, both determined at a resolution of 1.5 angstroms, showed that the aldehyde groups of 11a and 11b are covalently bound to cysteine 145 of M-pro. Both compounds showed good pharmacokinetic properties in vivo, and 11a also exhibited low toxicity, which suggests that these compounds are promising drug candidates.

引用

页码：1331 / +

页数：35

共 50 条

[41] Impact of Drug Repurposing on SARS-Cov-2 Main Protease
Umar Ndagi
Maryam Abdullahi
Asmau N. Hamza
Mohd G. Magaji
Ndumiso N. Mhlongo
Makun Babazhitsu
Hussaini Majiya
Hussaini Anthony Makun
Monsurat M. Lawal
Russian Journal of Physical Chemistry A, 2022, 96 : 3311 - 3330
[42] Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease
Deshmukh, Maya G.
Ippolito, Joseph A.
Zhang, Chun-Hui
Stone, Elizabeth A.
Reilly, Raquel A.
Miller, Scott J.
Jorgensen, William L.
Anderson, Karen S.
STRUCTURE, 2021, 29 (08) : 823 - +
[43] SARS-CoV-2 Main Protease Drug Design, Assay Development, and Resistance Studies
Tan, Bin
Joyce, Ryan
Tan, Haozhou
Hu, Yanmei
Wang, Jun
ACCOUNTS OF CHEMICAL RESEARCH, 2022, : 157 - 168
[44] Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking
Nandi, Sisir
Kumar, Mohit
Saxena, Anil Kumar
LETTERS IN DRUG DESIGN & DISCOVERY, 2022, 19 (05) : 413 - 427
[45] Structure-Based Virtual Screening and Biochemical Validation to Discover a Potential Inhibitor of the SARS-CoV-2 Main Protease
Gupta, Akshita
Rani, Chitra
Pant, Pradeep
Vijayan, Viswanathan
Vikram, Naval
Kaur, Punit
Singh, Tej Pal
Sharma, Sujata
Sharma, Pradeep
ACS OMEGA, 2020, 5 (51): : 33151 - 33161
[46] Structure-Based Discovery of the SARS-CoV-2 Main Protease Noncovalent Inhibitors from Traditional Chinese Medicine
Jin, Xiaojie
Zhang, Min
Fu, Beibei
Li, Mi
Yang, Jingyi
Zhang, Zhiming
Li, Chenghao
Zhang, Huijuan
Wu, Haibo
Xue, Weiwei
Liu, Yongqi
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (04) : 1319 - 1330
[47] Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: anin silicorepurposing study
Ferraz, Witor Ribeiro
Gomes, Renan Augusto
Novaes, Andre Luis
Goulart Trossini, Gustavo Henrique
FUTURE MEDICINAL CHEMISTRY, 2020, 12 (20) : 1815 - 1828
[48] Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease
Huynh, Tien
Wang, Haoran
Luan, Binquan
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2020, 22 (43) : 25335 - 25343
[49] Targeting allosteric pockets of SARS-CoV-2 main protease Mpro
Bhat, Zahoor Ahmad
Chitara, Dheeraj
Iqbal, Jawed
Sanjeev, B. S.
Madhumalar, Arumugam
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (14): : 6603 - 6618
[50] Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
Panda, Pritam Kumar
Arul, Murugan Natarajan
Patel, Paritosh
Verma, Suresh K.
Luo, Wei
Rubahn, Horst-Gunter
Mishra, Yogendra Kumar
Suar, Mrutyunjay
Ahuja, Rajeev
SCIENCE ADVANCES, 2020, 6 (28)

← 1 2 3 4 5 →